To verify the effect of ERCC6L on cell proliferation, we knocked down ERCC6L by shRNA (Supplementary Figure 1B) in another two cancer cell lines, a breast cancer cell line MDA-MB-231 and a kidney cancer cell line 786-0. This evidence concerns the gene ERCC6L and breast carcinoma.